Trxade Group Stock News

TAMPA, FL / ACCESSWIRE / April 25, 2022 / TRxADE HEALTH INC. (NASDAQ:MEDS) , is a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the

TRxADE HEALTH, Inc. (MEDS) CEO Suren Ajjarapu on Q4 2021 Results - Earnings Call Transcript

TAMPA, FL / ACCESSWIRE / March 14, 2022 / TRxADE HEALTH INC. (NASDAQ:MEDS), is a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the p

TAMPA, FL / ACCESSWIRE / February 9, 2022 / TRxADE HEALTH, INC . (NASDAQ:MEDS)("TRxADE" or the "Company"), a health services IT company focused on digitalizing the retail pharmacy experience by optimi

Trxade Health Inc (MEDS) shares closed today 12.0% lower than it did at the end of yesterday. The stock is currently up 9.7% year-to-date, down 52.1% over the past 12 months, and up 48.0% over the past five years. Today, the Dow Jones Industrial Average fell 1.0%, and the S&P 500 fell 1.9%. Trading Activity Shares traded as high as $2.70 and as low as $2.24 this week.Shares closed 78.9% below its 52-week high and 1.8% above its 52-week low.Trading volume this week was 58.9% lower than the 10-day average and 26.7% lower than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.7. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price lags the S&P 500 Index today, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price lags the Dow Jones Industrial Average today, lags it on a 1-year basis, and lags it on a 5-year basis The company share price lags the performance of its peers in the Industrials industry sector today, lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 217.1% The company's stock price performance over the past 12 months lags the peer average by 287.7% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Trxade Health Inc (MEDS) shares closed today at 1.8% above its 52 week low of $2.24, giving the company a market cap of $21M. The stock is currently up 9.7% year-to-date, down 52.1% over the past 12 months, and up 48.0% over the past five years. This week, the Dow Jones Industrial Average rose 1.1%, and the S&P 500 rose 0.1%. Trading Activity Trading volume this week was 26.7% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.7. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Industrials industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 217.1% The company's stock price performance over the past 12 months lags the peer average by 287.7% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Trxade Health Inc (MEDS) shares closed today 11.4% higher than it did at the end of yesterday. The stock is currently up 11.4% year-to-date, down 50.3% over the past 12 months, and up 50.3% over the past five years. Today, the Dow Jones Industrial Average rose 0.6%, and the S&P 500 rose 0.6%. Trading Activity Shares traded as high as $2.67 and as low as $2.24 this week.Shares closed 75.7% below its 52-week high and 17.4% above its 52-week low.Trading volume this week was 80.2% higher than the 10-day average and 247.7% higher than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.7. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price beats the S&P 500 Index today, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average today, lags it on a 1-year basis, and lags it on a 5-year basis The company share price beats the performance of its peers in the Industrials industry sector today, lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 986.9% The company's stock price performance over the past 12 months lags the peer average by 246.5% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Trxade Health Inc (MEDS) shares closed today at 0.4% above its 52 week low of $2.52, giving the company a market cap of $20M. The stock is currently down 52.2% year-to-date, down 51.8% over the past 12 months, and up 44.6% over the past five years. This week, the Dow Jones Industrial Average rose 1.6%, and the S&P 500 rose 2.3%. Trading Activity Trading volume this week was 65.9% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.6. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Industrials industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 253.2% The company's stock price performance over the past 12 months lags the peer average by 235.8% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

TRxADE HEALTH (NASDAQ:MEDS) was downgraded by Zacks Investment Research from a buy rating to a hold rating in a research note issued to investors on Thursday, Zacks.com reports. According to Zacks, TRxADE HEALTH INC. is a health services IT company focused on digitalizing the retail pharmacy experience. TRxADE HEALTH INC., formerly known as TRxADE Group [] The post TRxADE HEALTH (NASDAQ:MEDS) Stock Rating Lowered by Zacks Investment Research appeared first on ETF Daily News .

TAMPA, FL / ACCESSWIRE / November 17, 2021 / TRxADE HEALTH, INC . (NASDAQ:MEDS), a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the

Shares of Trxade Group Inc (OTCMKTS:TRXD) passed below its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of $4.61 and traded as low as $3.95. Trxade Group shares last traded at $3.95, with a volume of 39,681 shares changing hands. The businesss fifty day simple moving average is []

TRxADE HEALTH, Inc. (MEDS) CEO Surendra Ajjarapu on Q3 2021 Results - Earnings Call Transcript

TAMPA, FL / ACCESSWIRE / October 11, 2021 / TRxADE HEALTH, INC. (NASDAQ:MEDS), a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the p

TAMPA, FL / ACCESSWIRE / September 28, 2021 / TRxADE HEALTH, INC. (NASDAQ:MEDS), a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the

TAMPA, FL / ACCESSWIRE / September 7, 2021 / TRxADE HEALTH, INC . (NASDAQ:MEDS), a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the